Literature DB >> 28270324

[Imaging methods used in the differential diagnosis between brain tumour relapse and radiation necrosis after stereotactic radiosurgery of brain metastases: Literature review].

I Menoux1, J-P Armspach2, G Noël3, D Antoni4.   

Abstract

After stereotactic radiosurgery for a cerebral metastasis, one of the dreaded toxicities is radionecrosis. In the follow-up of these patients, it is impossible to distinguish radiation necrosis from tumour relapse either clinically or with MRI. In current practice, many imaging methods are designed such as special sequences of MRI (dynamic susceptibility contrast perfusion and susceptibility-weighted imaging, diffusion), proton magnetic resonance spectroscopy, positron emission tomography, or more seldom 201-thallium single-photon emission computerized tomography. This article is a required literature analysis in order to establish a decision tree with the analysis of retrospective and prospective data.
Copyright © 2016 Société française de radiothérapie oncologique (SFRO). Published by Elsevier SAS. All rights reserved.

Entities:  

Keywords:  IRM; Imagerie; MRI; PET scan; Radionecrosis; Radionécrose; Spectro-RMN; TEP-scanographie

Mesh:

Year:  2016        PMID: 28270324     DOI: 10.1016/j.canrad.2016.07.098

Source DB:  PubMed          Journal:  Cancer Radiother        ISSN: 1278-3218            Impact factor:   1.018


  6 in total

1.  Editorial commentary to "18F-Fluorocholine PET uptake correlates with pathologic evidence of recurrent tumor after stereotactic radiosurgery for brain metastases" by Grkovski and colleagues.

Authors:  Pierre Lovinfosse; Selma Ben Mustapha; Nadia Withofs
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-06       Impact factor: 9.236

2.  Local recurrence and cerebral progression-free survival after multiple sessions of stereotactic radiotherapy of brain metastases: a retrospective study of 184 patients : Statistical analysis.

Authors:  Laure Kuntz; Clara Le Fèvre; Delphine Jarnet; Audrey Keller; Philippe Meyer; Caroline Bund; Isabelle Chambrelant; Delphine Antoni; Georges Noel
Journal:  Strahlenther Onkol       Date:  2022-03-16       Impact factor: 4.033

Review 3.  Mechanisms and Therapy for Cancer Metastasis to the Brain.

Authors:  Federica Franchino; Roberta Rudà; Riccardo Soffietti
Journal:  Front Oncol       Date:  2018-05-24       Impact factor: 6.244

4.  The individual risk of symptomatic radionecrosis after brain metastasis radiosurgery is predicted by a continuous function of the V12Gy.

Authors:  Jean-François Daisne; Clémentine De Ketelaere; Jacques Jamart
Journal:  Clin Transl Radiat Oncol       Date:  2021-01-14

5.  Clinical applicability of and changes in perfusion MR imaging in brain metastases after stereotactic radiotherapy.

Authors:  M Kerkhof; I Ganeff; R G J Wiggenraad; G J Lycklama À Nijeholt; S Hammer; M J B Taphoorn; L Dirven; M J Vos
Journal:  J Neurooncol       Date:  2018-02-01       Impact factor: 4.130

Review 6.  Brain MR findings in patients treated with particle therapy for skull base tumors.

Authors:  Gisela Viselner; Lisa Farina; Federica Lucev; Elena Turpini; Luca Lungarotti; Ana Bacila; Alberto Iannalfi; Emma D'Ippolito; Barbara Vischioni; Sara Ronchi; Enrico Marchioni; Francesca Valvo; Stefano Bastianello; Lorenzo Preda
Journal:  Insights Imaging       Date:  2019-09-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.